Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05529316
Title A Study of Botensilimab (AGEN1181) for the Treatment of Advanced Melanoma
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Agenus Inc.
Age Groups: adult | senior
Covered Countries USA | ITA | GBR | FRA | ESP | DEU | BEL

No variant requirements are available.